the acelrx fiscal year 2016 financial results conference call is held in the fourth quarter fiscal year 2016. the acelrx has been a successful business organization and its success has been a key step in the development of a new opioid. the acelrx has been a successful commercial organization and its success has been a key milestone in the development of this drug. the most important milestone was the submission of a new drug application or national drug application for the development of the drug, the development of the drug by the FDA. the potential approval of the drug application or national drug for the drug was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the potential approval of the drug by the FDA was the development of the drug and the development of the drug and the development of the drug in the united states. the development of the drug and its therapeutic potential are discussed.